Showing results (461-470 of 496) with videos related to

Sort By:
Pageof 50
Expert Opinion on Biological Therapy|March 17, 2026
A review of the clinical efficacy of monoclonal antibody (mAb)-based therapies for relapsed/refractory multiple myeloma (RRMM)Yuxin Liu, Ji Hyun Lee, Clifton C Mo, et al.
Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice|November 22, 2023
Canadian respiratory therapists who considered leaving their clinical position experienced elevated moral distress and adverse psychological and functional outcomes during the COVID-19 pandemicAndrea M D'Alessandro-Lowe, Kimberly Ritchie, Andrea Brown, et al.
Blood Advances|February 9, 2021
COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experienceKatie Maurer, Anna Saucier, Haesook T Kim, et al.
Biomolecules|July 29, 2025
Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19Edward Richardson, Clifton C Mo, Eleonora Calabretta, et al.
Blood|October 20, 2010
Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiationPatricia Pérez-Galán, Helena Mora-Jensen, Marc A Weniger, et al.
Cancer|February 15, 2022
Quality of life, psychological distress, and prognostic perceptions in patients with multiple myelomaElizabeth K O'Donnell, Yael N Shapiro, Andrew J Yee, et al.
Blood Advances|July 18, 2022
Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myelomaElizabeth K O'Donnell, Yael N Shapiro, Andrew J Yee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative StudyJae-Gahb Park, Duck-Woo Kim, Chang Won Hong, et al.
Science (New York, N.Y.)|March 19, 2026
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineeringXiaojing Chen, Zhiyuan Mao, E Motunrayo Kolawole, et al.
Pageof 50